Literature DB >> 16323151

Doppler and biophysical assessment in growth restricted fetuses: distribution of test results.

A A Baschat1,2, H L Galan3, A Bhide4, C Berg5, M L Kush1, D Oepkes6, B Thilaganathan4, U Gembruch5, C R Harman1.   

Abstract

OBJECTIVE: Multi-vessel Doppler ultrasonography and biophysical profile scoring (BPS) are used in the surveillance of growth restricted fetuses (IUGR). The interpretation of both tests performed concurrently may be complex. This study examines the relationship between Doppler ultrasonography and biophysical test results in IUGR fetuses.
METHODS: Three hundred and twenty-eight IUGR fetuses (abdominal circumference < 5th percentile, elevated umbilical artery (UA) pulsatility index (PI)) had concurrent surveillance with UA, middle cerebral artery (MCA) and ductus venosus (DV) Doppler ultrasonography and BPS (fetal tone, movement, breathing, maximal amniotic fluid pocket and fetal heart rate). Patients were stratified into three groups according to their Doppler examination: (1) abnormal UA alone; (2) brain sparing (MCA-PI > 2 SD below mean for gestational age); and (3) abnormal DV (PI > 2 SD above the mean for gestational age) and BPS groups: (1) normal (> 6/10); (2) equivocal (6/10); and (3) abnormal (< 6/10). Predictions of short-term perinatal outcomes by both modalities were compared for stratification. The distribution and concordance of Doppler and BPS test results were examined for the whole patient group and based on delivery prior to 32 weeks' gestation.
RESULTS: Abnormal UA Doppler results alone were observed in 109 fetuses (33.2%), brain sparing in 87 (26.5%) and an abnormal DV in 132 (40.2%). The BPS was normal in 158 (48.2%), equivocal in 68 (20.7%) and abnormal in 102 (31.1%). Both testing modalities stratified patients into groups with comparable acid-base disturbance and perinatal outcome. Of the nine possible test combinations the largest subgroups were: abnormal UA alone/normal BPS (n = 69; 21%) and abnormal DV Doppler/abnormal BPS (n = 62; 18.9%). Assessment of compromise by both testing modalities was concordant in 146 (44.5%) cases. In 182 fetuses with discordant results the BPS grade was better in 115 (63.2%, P < 0.0001). Marked disagreement of test abnormality was present in 57 (17.4%) fetuses. Of these, abnormal venous Doppler in the presence of a normal BPS constituted the largest group (Chi-square P < 0.002). Stratification was not significantly different in patients delivered prior to 32 weeks' gestation.
CONCLUSION: Doppler ultrasonography and BPS effectively stratify IUGR fetuses into risk categories, but Doppler and BPS results do not show a consistent relationship with each other. Since fetal deterioration appears to be independently reflected in these two testing modalities further research is warranted to investigate how they are best combined. Copyright 2005 ISUOG.

Entities:  

Mesh:

Year:  2006        PMID: 16323151     DOI: 10.1002/uog.2657

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  15 in total

Review 1.  Reducing stillbirths: screening and monitoring during pregnancy and labour.

Authors:  Rachel A Haws; Mohammad Yawar Yakoob; Tanya Soomro; Esme V Menezes; Gary L Darmstadt; Zulfiqar A Bhutta
Journal:  BMC Pregnancy Childbirth       Date:  2009-05-07       Impact factor: 3.007

2.  Delayed maturation of auditory-evoked responses in growth-restricted fetuses revealed by magnetoencephalographic recordings.

Authors:  Isabelle Kiefer; Eric Siegel; Hubert Preissl; Maureen Ware; Burkhard Schauf; Curtis Lowery; Hari Eswaran
Journal:  Am J Obstet Gynecol       Date:  2008-06-04       Impact factor: 8.661

3.  Combined sonographic testing index and prediction of adverse outcome in preterm fetal growth restriction.

Authors:  Anthony O Odibo; Katherine R Goetzinger; Alison G Cahill; Linda Odibo; George A Macones
Journal:  Am J Perinatol       Date:  2013-04-01       Impact factor: 1.862

4.  FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction.

Authors:  Nir Melamed; Ahmet Baschat; Yoav Yinon; Apostolos Athanasiadis; Federico Mecacci; Francesc Figueras; Vincenzo Berghella; Amala Nazareth; Muna Tahlak; H David McIntyre; Fabrício Da Silva Costa; Anne B Kihara; Eran Hadar; Fionnuala McAuliffe; Mark Hanson; Ronald C Ma; Rachel Gooden; Eyal Sheiner; Anil Kapur; Hema Divakar; Diogo Ayres-de-Campos; Liran Hiersch; Liona C Poon; John Kingdom; Roberto Romero; Moshe Hod
Journal:  Int J Gynaecol Obstet       Date:  2021-03       Impact factor: 3.561

5.  Circulating levels of inflammatory markers in intrauterine growth restriction.

Authors:  Theodora Boutsikou; George Mastorakos; Marialena Kyriakakou; Alexandra Margeli; Demetrios Hassiakos; Ioannis Papassotiriou; Christina Kanaka-Gantenbein; Ariadne Malamitsi-Puchner
Journal:  Mediators Inflamm       Date:  2010-06-03       Impact factor: 4.711

Review 6.  Defining normal and abnormal fetal growth: promises and challenges.

Authors:  Jun Zhang; Mario Merialdi; Lawrence D Platt; Michael S Kramer
Journal:  Am J Obstet Gynecol       Date:  2010-01-13       Impact factor: 8.661

7.  Fetal growth parameters and birth weight: their relationship to neonatal body composition.

Authors:  W Lee; M Balasubramaniam; R L Deter; S S Hassan; F Gotsch; J P Kusanovic; L F Gonçalves; R Romero
Journal:  Ultrasound Obstet Gynecol       Date:  2009-04       Impact factor: 7.299

Review 8.  Diagnosis and management of fetal growth restriction.

Authors:  Jacqueline E A K Bamfo; Anthony O Odibo
Journal:  J Pregnancy       Date:  2011-04-13

9.  Doppler and birth weight Z score: predictors for adverse neonatal outcome in severe fetal compromise.

Authors:  Fernanda C da Silva; Renato A Moreira de Sá; Paulo R N de Carvalho; Laudelino M Lopes
Journal:  Cardiovasc Ultrasound       Date:  2007-03-20       Impact factor: 2.062

10.  Umbilical artery Doppler study as a predictive marker of perinatal outcome in preterm small for gestational age infants.

Authors:  Young Ji Byun; Haeng-Soo Kim; Jeong In Yang; Joon Hyung Kim; Ho Yeon Kim; Suk Joon Chang
Journal:  Yonsei Med J       Date:  2009-02-24       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.